Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study

1. Castellanos, M.
2. Sobrino, T.
3. Millán, M.
4. García, M.
5. Arenillas, J.
6. Nombela, F.
7. Brea, D.
8. Perez De La Ossa, N.
9. Serena, J.
10. Vivancos, J.
11. Castillo, J.
12. Dávalos, A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1161/STROKEAHA.106.481556 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

•